- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 51.58M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.15B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.11B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $4.77M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $4.89M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $133.75M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $191.92M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.04B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.1B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.64B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.64B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.62B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.77B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.75B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.83B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 58.99M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $34.11M |
| Capex | Q1 2025 · Mar 31, 2024 | $22.64M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $25.43M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.31B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.34B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $41.76M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$3.75M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $9.52M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.98B |